Laboratory Products
GLP-1R reporter cell line advances diabetes and obesity research
Jul 02 2024
AMSBIO has introduced a new Glucagon-Like Peptide 1 Receptor (GLP-1R) reporter cell line, designed to advance research in diabetes and obesity. GLP-1R plays a crucial role in blood sugar regulation by enhancing glucose-stimulated insulin secretion, making it a key target for type 2 diabetes treatments. The regulation of the GLP-1R signalling pathway has led to the development of several FDA-approved GLP-1 agonists. Additionally, GLP-1R agonists aid in weight management, reduce cardiovascular disease risk, and protect pancreatic beta cells.
The new GLP-1R/CRE Luciferase Reporter HEK293 cell line measures luciferase activity to monitor GLP-1R activation in cells. This cell line is ideal for cell-based binding assays and screening human GLP-1R agonists. Its functionality has been validated in dose-response assays with both peptide and small molecule agonists.
AMSBIO has also launched gastric inhibitory polypeptide receptor (GIPR) and glucagon receptor (GCGR) reporter cell lines to complement the GLP-1R cell line. These receptors are vital for blood sugar regulation, and dual agonists targeting GIPR/GCGR and GLP-1R show promise for type 2 diabetes and obesity treatments. Together, these cell lines offer a robust platform for screening combination therapies by measuring the activity of co-stimulatory targets in response to agonists.
To assist investigations into muscle loss caused by GLP-1R agonists, AMSBIO also offers a range of skeletal muscle research products.
More information online
Digital Edition
International Labmate Buyers' Guide 2024/25
June 2024
Buyers' Guide featuring: Product Listings & Manufacturers Directory Chromatography Articles - Enhancing HPLC Field Service with fast-response, non-invasive flowmeters - Digital transformatio...
View all digital editions
Events
Jul 03 2024 Gandhinagar, India
Jul 07 2024 Dublin, Ireland
Jul 20 2024 Denver, CO, USA
Jul 21 2024 Cape Town, South Africa
Jul 28 2024 San Diego, CA USA